Entrada Therapeutics

TRDA • NASDAQ • Stock Fundamentals

Entrada Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Dipal Doshi, with a market cap of $245.0M.

Market Cap$245.0M

Employees159.0

CEODipal Doshi

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 6 days agoQ1 2026

Next EarningsAug 5, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Entrada Therapeutics

Entrada Therapeutics (TRDA) has a market capitalization of $245.0M and trades on NASDAQ.

Entrada Therapeutics has approximately 159 employees.